C8 Glucosyl(beta) Ceramide (d18:1/8:0)
| Catalog Number | BL-M001012 |
| CAS Number | 111956-47-9 |
| Description | C8 Glucosyl(beta) Ceramide (d18:1/8:0) Playing a pivotal role in cellular communication, this lipid compound has been linked to a wide array of medical conditions, such as cancer and neurodegenerative maladies. It represents a promising avenue for therapeutic intervention within the realm of biomedical research. |
 | |
| IUPAC Name | N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]octanamide |
| Synonyms | D-glucosyl-beta-1,1'-N-octanoyl-D-erythro-sphingosine; N-{(2S,3R,4E)-1-[(beta-D-glycero-Hexopyranosyl)oxy]-3-hydroxyoctadec-4-en-2-yl}octanamide; C8 beta-D-glucosyl ceramide; N-(octanoyl)-1-beta-glucosyl-sphing-4-enine GlcCer(d18:1/8:0) |
| Molecular Weight | 587.8 |
| Molecular Formula | C32H61NO8 |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 65.38%, H 10.46%, N 2.38%, O 21.77% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)NC(=O)CCCCCCC)O |
| InChI | InChI=1S/C32H61NO8/c1-3-5-7-9-10-11-12-13-14-15-16-18-19-21-26(35)25(33-28(36)22-20-17-8-6-4-2)24-40-32-31(39)30(38)29(37)27(23-34)41-32/h19,21,25-27,29-32,34-35,37-39H,3-18,20,22-24H2,1-2H3,(H,33,36)/b21-19+/t25-,26+,27?,29+,30?,31?,32+/m0/s1 |
| InChI Key | LCEXEEHGNKGJES-LSHBQEOXSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
